These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7954491)
1. Infusional 5-fluorouracil in breast cancer. Ng JS; Cameron DA; Leonard RC Cancer Treat Rev; 1994 Oct; 20(4):357-64. PubMed ID: 7954491 [No Abstract] [Full Text] [Related]
2. Continuous infusional 5-fluorouracil in breast cancer or the revival of an old drug? Smith IE Ann Oncol; 1996 Oct; 7(8):771-2. PubMed ID: 8922189 [No Abstract] [Full Text] [Related]
3. Infusional fluorouracil in breast cancer treatment. Fox KR Cancer Invest; 1996; 14(2):178-9. PubMed ID: 8597903 [No Abstract] [Full Text] [Related]
4. [Infusiontherapy with 5-fluorouracil ("infusional" 5-FU) in solid tumors]. Wilke H; Stahl M; Köster W; Vanhöfer U Med Klin (Munich); 2000 Jun; 95 Suppl 1():3-8. PubMed ID: 10941246 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen. Bonnefoi H; Smith IE; O'Brien ME; Seymour MT; Powles TJ; Allum WH; Ebbs S; Baum M Br J Cancer; 1996 Feb; 73(3):391-6. PubMed ID: 8562348 [TBL] [Abstract][Full Text] [Related]
6. Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience. Ross PJ; Webb A; Cunningham D; Prendiville J; Norman AR; Oates J J Infus Chemother; 1996; 6(3):141-4. PubMed ID: 9229326 [No Abstract] [Full Text] [Related]
7. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin. Klaassen U; Wilke H; Seeber S J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323 [TBL] [Abstract][Full Text] [Related]
8. Continuous infusional chemotherapy for early breast cancer: the Royal Marsden Hospital experience. Smith IE Recent Results Cancer Res; 1998; 152():323-7. PubMed ID: 9928569 [TBL] [Abstract][Full Text] [Related]
9. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges. Lokich JJ; Moore CL; Anderson NR Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006 [TBL] [Abstract][Full Text] [Related]
10. Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancer. Eisen T; Smith IE; Johnston S; Ellis PA; Prendiville J; Seymour MT; Walsh G; Ashley S J Clin Oncol; 1998 Apr; 16(4):1350-7. PubMed ID: 9552036 [TBL] [Abstract][Full Text] [Related]
11. Continuous 5-fluorouracil in the treatment of breast cancer. Cameron DA; Gabra H; Leonard RC Br J Cancer; 1994 Jul; 70(1):120-4. PubMed ID: 8018521 [TBL] [Abstract][Full Text] [Related]
12. Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer. Stuart NS; McIllmurray MB; Bishop JL; Johnston SR; Price CG; O'Reilly SM; Joffe JK; Neave F; Whipp EC Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):152-6. PubMed ID: 18083354 [TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil and folinic acid: summary of clinical experience. Creaven PJ Adv Exp Med Biol; 1988; 244():303-11. PubMed ID: 3073664 [No Abstract] [Full Text] [Related]
14. An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer. Bonnefoi H; Biganzoli L; Cufer T; Mauriac L; Hamilton A; Schaefer P; Piccart M Breast Cancer Res Treat; 2001 Nov; 70(1):55-63. PubMed ID: 11768362 [TBL] [Abstract][Full Text] [Related]
15. Combined androgen and antimetabolite therapy of advanced female breast cancer. A report of the cooperative breast cancer group. Goldenberg IS; Sedransk N; Volk H; Segaloff A; Kelley RM; Haines CR Cancer; 1975 Aug; 36(2):308-10. PubMed ID: 1098764 [TBL] [Abstract][Full Text] [Related]
16. The French experience with infusional 5-fluorouracil in advanced colorectal cancer. de Gramont A; Louvet C; Krulik M J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324 [TBL] [Abstract][Full Text] [Related]
17. Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer. Gabra H; Cameron DA; Lee LE; Mackay J; Leonard RC Br J Cancer; 1996 Dec; 74(12):2008-12. PubMed ID: 8980405 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of continuous infusional 5-fluorouracil, doxorubicin and cyclophosphamide in breast cancer. Mackay HJ; Bissett D; Twelves C; Vasey PA Clin Oncol (R Coll Radiol); 1999; 11(3):174-8. PubMed ID: 10465471 [TBL] [Abstract][Full Text] [Related]
19. A phase II study of docetaxel, doxorubicin, and infusional 5-fluorouracil in the treatment of patients with locally advanced breast cancer. Thatai LC; Vishnubhotla P; Biernat L; Flaherty L; LoRusso P; Simon M; Stephens D; Vereeke K; Abrams J; Bouwman D; Philip PA Am J Clin Oncol; 2006 Oct; 29(5):484-9. PubMed ID: 17023784 [TBL] [Abstract][Full Text] [Related]
20. A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: a preliminary report. Ansfield F; Klotz J; Nealon T; Ramirez G; Minton J; Hill G; Wilson W; Davis H; Cornell G Cancer; 1977 Jan; 39(1):34-40. PubMed ID: 318916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]